Foreign companies have been enhancing their investments in China, underscoring the country's significant potential and enduring attractiveness as a premier investment destination.
European aircraft manufacturer Airbus, for instance, has put its A320 Family Final Assembly Line Asia (FALA) in north China's Tianjin Municipality into operation in 2008.
As the first Airbus production line established outside Europe, the FALA has been operating for over 15 years and has become a role model of successful China-Europe cooperation.
The 700th A320 family aircraft assembled in China was officially delivered on July 8.
Airbus has ambitious plans for further expansion in China. According to the aircraft manufacturer, the second assembly line is expected to be completed and commence official operation at the beginning of 2026.
Xu Gang, CEO of Airbus China, said the company also plans to allocate 20 percent of its global production capacity for the A320 series aircraft to China.
"Through tangible actions, we are showing our confidence and support to China's investment environment. Our supply chain in China is rapidly expanding, and our industrial cooperation in the country has already reached a value of 1 billion U.S. dollars," explained Xu.
Considering China's high-level economic opening up, Airbus will further enhance its investments in areas such as sustainable aviation fuels, a biofuel used to power aircraft with a smaller carbon footprint, in the country.
"We see the favorable conditions in China, which include advantages in resource endowment, green energy, and large-scale production capabilities. We are eager to collaborate with all stakeholders in the ecosystem and firmly believe that this cooperation will serve as significant new quality productive forces," added Xu.
China's inclusive and innovative ecosystem, along with its favorable business environment, has also created extensive opportunities for foreign-invested brands to establish their presence in the Chinese market.
Medtronic, one of the first multinational medical technology companies to enter China, has been steadily expanding its operations along the entire value chain in the country.
The construction of the Medtronic Kanghui Changzhou Science and Technology Park began in Changzhou National High-tech District in east China's Jiangsu Province in 2023, aiming to enhance the research and development as well as production capabilities of advanced medical devices and intelligent equipment in the Yangtze River Delta region.
Brett Wall, the Executive Vice President of the U.S.-based firm, said he is bullish on the company's development in the Chinese market.
"When I look at our business in China, we've found ways to grow and to continue to grow here and at the same time utilize the unique resources, the unique technology, the unique abilities that we have here in China, and frankly, that makes us a better company," said Wall.
Foreign companies boost investments in China
Foreign companies boost investments in China
